UBS Group’s Immune Pharmaceuticals Inc. IMNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5
| Closed | – | – | 7433 |
|
|
2018
Q2 | $0 | Sell |
5
-15,643
| -100% | – | ﹤0.01% | 7357 |
|
|
2018
Q1 | $5K | Sell |
15,648
-71,866
| -82% | -$23K | ﹤0.01% | 6392 |
|
|
2017
Q4 | $50K | Buy |
87,514
+80,952
| +1,234% | +$46.3K | ﹤0.01% | 4894 |
|
|
2017
Q3 | $10K | Buy |
6,562
+3,695
| +129% | +$5.63K | ﹤0.01% | 6005 |
|
|
2017
Q2 | $9K | Buy |
+2,867
| New | +$9K | ﹤0.01% | 5926 |
|
|
2017
Q1 | – | Sell |
-5,003
| Closed | -$18K | – | 7014 |
|
|
2016
Q4 | $18K | Buy |
5,003
+1,831
| +58% | +$6.59K | ﹤0.01% | 5650 |
|
|
2016
Q3 | $18K | Buy |
+3,172
| New | +$18K | ﹤0.01% | 5508 |
|
|
2016
Q2 | – | Sell |
-95
| Closed | -$1K | – | 7062 |
|
|
2016
Q1 | $1K | Buy |
95
+41
| +76% | +$432 | ﹤0.01% | 6620 |
|
|
2015
Q4 | $1K | Sell |
54
-306
| -85% | -$5.67K | ﹤0.01% | 6765 |
|
|
2015
Q3 | $9K | Buy |
360
+249
| +224% | +$6.23K | ﹤0.01% | 6005 |
|
|
2015
Q2 | $4K | Buy |
111
+81
| +270% | +$2.92K | ﹤0.01% | 6400 |
|
|
2015
Q1 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 6571 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6825 |
|